Health Care & Life Sciences » Biotechnology | NanoString Technologies Inc.

NanoString Technologies Inc. | Ownership

Companies that own NanoString Technologies Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
ARK Investment Management LLC
2,625,472
8.81%
391,070
1.4%
06/30/2018
Cadian Capital Management LP
2,155,490
7.24%
-338,610
1.57%
06/30/2018
Wellington Management Co. LLP
1,688,218
5.67%
239,738
0.01%
06/30/2018
BlackRock Fund Advisors
1,590,863
5.34%
81,825
0%
06/30/2018
The Vanguard Group, Inc.
1,061,486
3.56%
150,653
0%
06/30/2018
Neuberger Berman Investment Advisers LLC
1,003,301
3.37%
-24,798
0.02%
06/30/2018
Morgan Stanley & Co. International Plc
814,400
2.73%
814,400
0.47%
06/30/2018
Millennium Management LLC
775,065
2.6%
-79,240
0.02%
06/30/2018
RE Advisers Corp.
521,132
1.75%
0
0.12%
06/30/2018
Polar Capital LLP
500,000
1.68%
108,081
0.02%
06/30/2018

About NanoString Technologies

View Profile
Address
530 Fairview Avenue North
Seattle Washington 98109
United States
Employees -
Website http://www.nanostring.com
Updated 07/08/2019
NanoString Technologies, Inc. engages in the provision of life science tools for translational research and molecular diagnostic products. It offers analysis solutions, gene expression panels, protein assays, DNA Assaya, miRNA assays, vantage 3D assays, custom solutions, sample prep and nCounter consumables, and nDesign gateway. The company was founded by Amber Ratcliffe, Krassen Dimitrov, and Dwayne Dunaway on June 20, 2003 and is headquartered in Seattle, WA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.